TrialEuropean journal of drug metabolism and pharmacokinetics2026

A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers.

Robert Niecestro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.